{"altmetric_id":9663030,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Peter Rossing, Steno Diabetes Center"],"first_seen_on":"2016-07-13T20:49:45+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1468366605,"links":["http:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02829177","http:\/\/clinicaltrials.gov\/show\/NCT02829177"],"nct_id":"NCT02829177","pubdate":"2015-03-27T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Microalbuminuria and Allopurinol in Type 1 Diabetes (MIKAL)","type":"clinical_trial_study_record"},"altmetric_score":{"score":7,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7},"context_for_score":{"all":{"total_number_of_other_articles":8069307,"mean":6.8479199559378,"rank":1149575,"this_scored_higher_than_pct":84,"this_scored_higher_than":6846068,"rank_type":"exact","sample_size":8069307,"percentile":84},"similar_age_3m":{"total_number_of_other_articles":258769,"mean":11.688063408149,"rank":52276,"this_scored_higher_than_pct":78,"this_scored_higher_than":203144,"rank_type":"exact","sample_size":258769,"percentile":78},"this_journal":{"total_number_of_other_articles":22610,"mean":10.520266707948,"rank":3836,"this_scored_higher_than_pct":74,"this_scored_higher_than":16910,"rank_type":"exact","sample_size":22610,"percentile":74},"similar_age_this_journal_3m":{"total_number_of_other_articles":1011,"mean":12.015562376238,"rank":136,"this_scored_higher_than_pct":72,"this_scored_higher_than":732,"rank_type":"exact","sample_size":1011,"percentile":72}}},"demographics":[],"counts":{"total":{"posts_count":1},"news":{"unique_users_count":1,"unique_users":["bioportfolio"],"posts_count":1}},"posts":{"news":[{"title":"Microalbuminuria and Allopurinol in Type 1 Diabetes","url":"http:\/\/ct.moreover.com\/?a=27239700629&p=1pl&v=1&x=ztJx1Nk08LvFC9CbYps6BA","license":"public","citation_ids":[9663030,9663030],"posted_on":"2016-07-12T23:36:45+00:00","summary":"Summary The objective is to determine if lowering serum uric acid by means of allopurinol in the course of kidney disease may be effective in preventing or improving albuminuria and renal function in Type 1 Diabetic patients.","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}}]}}